Protekt Therapeutics Ltd announced that it as entered into an agreement to receive $3,600,000 in an equity round of funding co-led by new investors Fonds de solidarité FTQ and Bukwang Pharmaceutical Co., Ltd. (KOSE:A003000) on November 13, 2019. The transaction included participation from existing investors FutuRX, OrbiMed Advisors LLC, Johnson & Johnson Innovation - JJDC, Inc., Takeda Ventures, Inc., and RMGP Biopharma Fund, a fund managed by RM Global Partners LLC, Investment Arm. The transaction is expected to close within a week.